Evaluation of the INNOVANCE PFA P2Y test cartridge: sensitivity to P2Y(12) blockade and influence of anticoagulant. (Q45872542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Evaluation of the INNOVANCE PFA P2Y test cartridge: sensitivity to P2Y(12) blockade and influence of anticoagulant (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Abbie Edwards

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Joseph A Jakubowski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Andreas R Rechner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Atsuhiro Sugidachi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

17 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

106-115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Novel antiplatelet agents in development: prasugrel, ticagrelor, and cangrelor and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

P2Y12 antagonism: promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Assessing the current role of platelet function testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Current options in platelet function testing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Measuring antiplatelet drug effects in the laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA-100.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y₁₂ receptor inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Relationship between degree of P2Y12 receptor blockade and inhibition of P2Y12-mediated platelet function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

The effect of ex vivo anticoagulants on whole blood platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

The importance of anticoagulant agents in measuring platelet aggregation in patients treated with clopidogrel and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2011.601361

10.3109/09537104.2011.601361

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21848368%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference